As of 2026-03-29, the Intrinsic Value of Phibro Animal Health Corp (PAHC) is 93.39 USD. This PAHC valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 53.88 USD, the upside of Phibro Animal Health Corp is 73.30%.
The range of the Intrinsic Value is 49.44 - 354.85 USD
Based on its market price of 53.88 USD and our intrinsic valuation, Phibro Animal Health Corp (PAHC) is undervalued by 73.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 49.44 - 354.85 | 93.39 | 73.3% |
| DCF (Growth 10y) | 61.32 - 390.51 | 108.99 | 102.3% |
| DCF (EBITDA 5y) | 35.16 - 56.51 | 45.29 | -15.9% |
| DCF (EBITDA 10y) | 47.69 - 76.20 | 60.78 | 12.8% |
| Fair Value | 56.80 - 56.80 | 56.80 | 5.43% |
| P/E | 26.15 - 41.13 | 32.45 | -39.8% |
| EV/EBITDA | 27.57 - 44.96 | 39.13 | -27.4% |
| EPV | 3.38 - 11.28 | 7.33 | -86.4% |
| DDM - Stable | 25.30 - 124.24 | 74.77 | 38.8% |
| DDM - Multi | 34.94 - 132.18 | 55.13 | 2.3% |
| Market Cap (mil) | 2,183.76 |
| Beta | 1.00 |
| Outstanding shares (mil) | 40.53 |
| Enterprise Value (mil) | 2,859.51 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.47% |
| Cost of Debt | 4.59% |
| WACC | 6.38% |